Skip to main content
. 2009 Nov 4;48(1):70–77. doi: 10.1128/JCM.01449-09

TABLE 3.

Characteristics of participants and parasite genotypes

Characteristic Position Amino acidsa 2001 2002 2005 2006 2007 P valuec
Ageb 22.1 ± 15.2 (2-75) 19.3 ± 14.0 (0-72) 23.1 ± 16.3 (1-65) 14.3 ± 11.8 (0-48) 9.63 ± 10.8 (2-46) 0.05
% Males 52.7 55.5 66.7 38.1 25.0 0.07
pfcrt 74 M/I/mix 31/42/9 (37.8/51.2/11.0)d 67/22/11 (67.0/22.0/11.0) 33/0/0 (100/0/0) 31/6/1 (81.6/15.8/2.6) 11/3/2 (68.8/18.8/12.5) <0.001
75 N/E/D/mix 31/28/13/10 (37.8/34.1/15.9/12.2) 67/7/15/11 (67.0/7.0/15.0/11.0) 33/0/0/0 (100/0/0/0) 31/1/5/1 (83.8/2.6/13.2/2.6) 11/1/2/2 (68.8/6.3/12.5/12.5) <0.001
76 K/T/mix 31/42/9 (37.8/51.2/11.0) 67/22/11 (67.0/22.0/11.0) 33/0/0 (100/0/0) 31/6/1 (81.6/15.8/2.6) 11/3/2 (68.8/18.8/12.5) <0.001
144 A/F/mix 63/12/7 (76.8/14.6/8.5) 75/17/8 (75.0/17.0/8.0) 36/0/0/ (100/0/0) 35/3/0 (92.1/7.9/0) 14/2/0 (87.5/12.5/0) 0.07
148 L/I/mix 63/12/7 (76.8/14.6/8.5) 75/17/8 (75.0/17.0/8.0) 36/0/0 (100/0/0) 35/3/0 (92.1/7.9/0) 14/2/0 (87.5/12.5/0) 0.07
194 I/T/mix 63/12/7 (76.8/14.6/8.5) 75/17/8 (75.0/17.0/8.0) 36/0/0 (100/0/0) 35/3/0 (92.1/7.9/0) 14/2/0 (87.5/12.5/0) 0.07
220 A/S/mix 31/42/9 (37.8/51.2/11.0) 65/24/1 (65.0/24.0/11.0) 36/0/0 (100/0/0) 31/6/1 (81.6/15.8/2.6) 11/4/1 (68.8/25.0/6.3) <0.001
271 Q/E/mix 31/42/9 (37.8/51.2/11.0) 68/22/10 (68.0/22.0/10.0) 36/0/0 (100/0/0) 31/5/2 (81.6/13.2/5.3) 11/4/1 (68.8/25.0/6.3) <0.001
326 N/S/mix 54/23/6 (65.9/28.0/7.3) 93/3/4 (93.0/3.0/4.0) 36/0/0 (100/0/0) 36/2/0 (94.7/5.3/0) 15/0/1 (92.1/0/6.3) <0.001
333 T/S/mix 59/17/7 (72.0/20.7/8.5) 76/16/8 (76.0/16.0/8.0) 36/0/0 (100/0/0) 35/3/0 (92.1/7.9/0) 13/2/1 (81.3/12.5/6.3) 0.02
356 I/T/mix 55/24/4 (67.1/29.3/4.9) 90/6/4 (90.0/6.0/4.0) 36/0/0 (100/0/0) 36/2/0 (92.1/5.3/0) 15/0/1 (93.8/0/6.3) <0.001
371 R/I/mix 49/28/6 (59.8/34.1/7.3) 89/7/4 (89.0/7.0/4.0) 36/0/0 (100/0/0) 35/1/2 (92.1/2.6/5.3) 13/1/2 (81.3/6.3/12.5) <0.001
pfmdr1 130 E/K 66/1 (98.5/1.5) 90/1 (98.9/1.1) 33/0 (100/0) 35/0 (100/0) 13/1 (92.9/7.1)
184 Y/F/mix 53/8/5 (80.3/12.7/7.9) 72/7/12 (79.1/7.7/13.2) 33/0/0 (100/0/0) 31/3/1 (88.6/8.6/2.9) 13/1/0 (92.9/7.1/0) 0.32
1042 N/D/mix 55/8/4 (83.3/12.1/6.0) 80/4/7 (87.9/4.4/7.7) 33/0/0 (100/0/0) 33/3/0 (91.7/8.3/0) 12/1/1 (85.7/7.1/7.1) 0.17
1109 V/I/mix 62/0/4 (93.9/0/6.1) 91/1/0 (98.9/1.1/0) 33/0/0 (100/0/0) 33/3/0 (91.7/8.3/0) 13/0/0 (100/0/0)
pfdhfr 51 N/I/mix 4/71/0 (5.3/94.7/0) 6/39/5 (12.0/78.0/10.0) 1/23/0 (4.2/95.8/0) 10/24/0 (29.4/70.6/0) 3/8/0 (27.3/72.7/0) <0.001
59 C/R/mix 4/70/1 (5.3/93.3/1.3) 3/43/4 (6.0/86.0/8.0) 0/22/2 (0/91.7/8.3) 0/34/0 (0/100/0) 0/10/0 (0/100/0) 0.39
108 S/N/mix 4/71/0 (5.3/94.7/0) 1/48/1 (2.0/96.0/2.0) 0/24/0 (0/100/0) 0/35/0 (0/100/0) 0/11/0 (0/100/0) 0.38
164 I/L/mix 36/28/10 (48.6/37.8/13.5) 40/5/5 (80.0/10.0/10.0) 21/3/0 (87.5/12.5/0) 32/3/0 (91.4/8.6/0) 9/2/1 (75.0/16.7/8.3) <0.001
pfdhps 436 S/A/F/mix 21/25/10/7 (33.3/39.7/15.9/11.1) 44/33/8/10 (46.3/34.7/8.4/10.7) 10/19/1/0 (33.3/63.3/3.3/0) 25/3/0/8 (69.4/8.3/0/22.3) 13/0/1/2 (81.3/0/6.3/12.5) <0.001
437 A/G/mix 7/56/0 (11.1/88.9/0) 0/92/3 (0/96.8/3.2) 1/29/0 (3.3/96.7/0) 1/34/1 (2.8/94.4/2.8) 0/17/0 (0/100/0) <0.001
540 K/E/N/Y/mix 19/27/6/0/11 (30.2/63.5/9.5/0/17.4) 32/39/7/1/17 (33.3/40.6/7.3/1.0/17.7) 7/19/1/0/3 (23.3/63.3/3.3/0/10.0) 6/19/0/0/12 (16.2/51.4/0/0/32.4) 1/9/0/0/7 (5.9/52.9/0/0/41.2) 0.23
581 A/G/mix 47/8/8 (74.6/12.7/12.7) 61/20/16 (62.9/19.6/17.4) 23/4/3 (76.7/13.3/10.0) 8/16/13 (21.6/43.2/35.1) 4/9/4 (23.5/52.9/23.5) <0.001
613 A/T/S/mix 49/1/8/5 (77.8/1.6/12.7/8.0) 87/0/6/3 (90.6/0/6.3/3.1) 30/0/0/0 (100/0/0/0) 36/0/0/0 (100/0/0/0) 15/0/0/0 (100/0/0/0) <0.001
a

Boldface type indicates amino acid mutations.

b

Values are means ± standard deviations (minimum-maximum).

c

P values are for the correlation between each year. Data for mixed infections for each locus were excluded from the statistical analysis.

d

The data represent the number (percentage) of patients with the indicated genotype.